Literature DB >> 24239657

Forced exercise before or after induction of 6-OHDA-mediated nigrostriatal insult does not mitigate behavioral asymmetry in a hemiparkinsonian rat model.

Merrill R Landers1, Jefferson W Kinney2, Frank van Breukelen3.   

Abstract

Studies on exercise before and after toxin-induced hemiparkinsonism have reported promising findings in terms of amelioration of motor asymmetry in adult, 6-hydroxydopamine (6-OHDA) rats. However, recent studies have had more mixed results. Therefore, the purpose of this study was to further explore the notion of exercise, in particular forced exercise, as a potential neuroprotective therapy when implemented before and after 6-OHDA hemiparkinsonism. To explore this, two experiments were conducted: Experiment 1 - exercise before a 6-OHDA lesion; and, Experiment 2 - exercise after a 6-OHDA lesion. In Experiment 1, rats were randomly assigned into one of the two 4-week experimental conditions, a forced exercise condition and a non-exercise control condition. Then, after the experimental conditions rats were injected with 6-OHDA into the right medial forebrain bundle. In Experiment 2, rats were first injected with 6-OHDA and were then randomly assigned into one of the two 4-week experimental groups, a forced exercise group and a non-exercise control group. Outcomes in both experiments did not show any differences in terms of motor behavioral tests (i.e., apomorphine rotations, forelimb placement asymmetry, exploratory rearing) between the forced exercise and sedentary control groups. Based on our results and in light of the body of literature, it is possible that the stress of shock-motivated forced running utilized in this study may have canceled beneficial behavioral effects. Additionally, it is possible that the one-week delay in the forced exercise protocol implementation in Experiment 2 may have prevented behavioral rescue.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Exercise; Neuroprotection; Parkinson's disease

Mesh:

Substances:

Year:  2013        PMID: 24239657     DOI: 10.1016/j.brainres.2013.10.054

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

1.  Voluntary Exercise Boosts Striatal Dopamine Release: Evidence for the Necessary and Sufficient Role of BDNF.

Authors:  Guendalina Bastioli; Jennifer C Arnold; Maria Mancini; Adam C Mar; Begoña Gamallo-Lana; Khalil Saadipour; Moses V Chao; Margaret E Rice
Journal:  J Neurosci       Date:  2022-05-16       Impact factor: 6.709

2.  Prior exercise protects against oxidative stress and motor deficit in a rat model of Parkinson's disease.

Authors:  Leonam Oliver Durval Oliveira; Pedro Iuri Castro da Silva; Renato Pereira Rodrigues Filho; Raphaely Cristiny Sanches Progênio; Victor Douglas Pereira Silva de Oliveira; Renata Cunha Silva; Mariseth Carvalho de Andrade; Jofre Jacob da Silva Freitas; Katia Simone Kietzer
Journal:  Metab Brain Dis       Date:  2019-11-28       Impact factor: 3.584

3.  Transgenic LRRK2 (R1441G) rats-a model for Parkinson disease?

Authors:  Komal T Shaikh; Alvin Yang; Ekaterina Youshin; Susanne Schmid
Journal:  PeerJ       Date:  2015-05-12       Impact factor: 2.984

4.  A Novel Immunosuppressor, (5R)-5-Hydroxytriptolide, Alleviates Movement Disorder and Neuroinflammation in a 6-OHDA Hemiparkinsonian Rat Model.

Authors:  Ruijun Su; Min Sun; Wei Wang; Jianliang Zhang; Li Zhang; Junli Zhen; Yanjing Qian; Yan Zheng; Xiaomin Wang
Journal:  Aging Dis       Date:  2017-02-01       Impact factor: 6.745

5.  Time-course behavioral features are correlated with Parkinson's disease‑associated pathology in a 6-hydroxydopamine hemiparkinsonian rat model.

Authors:  Rui-Jun Su; Jun-Li Zhen; Wei Wang; Jian-Liang Zhang; Yan Zheng; Xiao-Min Wang
Journal:  Mol Med Rep       Date:  2017-12-13       Impact factor: 2.952

Review 6.  Rat Models of Vocal Deficits in Parkinson's Disease.

Authors:  Maryann N Krasko; Jesse D Hoffmeister; Nicole E Schaen-Heacock; Jacob M Welsch; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  Brain Sci       Date:  2021-07-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.